Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Heart (British Cardiac Society)
|
August 21, 2021
Dilated cardiomyopathy: the role of genetics, highlighted in a family with Filamin C (FLNC) variant
Jason N Dungu, Samantha G Langley, Amy Hardy-Wallace, et al.
Open Heart
|
April 17, 2025
Tale of three services: early UK experience with mavacamten treatment for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction
Edward Burford, Yande Kasolo, Jane Draper, et al.
Journal of Cardiac Failure
|
April 25, 2017
Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings
Hitesh C Patel, Carl Hayward, Jason N Dungu, et al.
Circulation. Heart Failure
|
September 14, 2016
Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis
Jason N Dungu, Sofia A Papadopoulou, Katharine Wykes, et al.
JACC. Cardiovascular Imaging
|
January 14, 2014
CMR-based differentiation of AL and ATTR cardiac amyloidosis
Jason N Dungu, Oswaldo Valencia, Jennifer H Pinney, et al.
Cardiology Journal
|
February 11, 2020
Stress perfusion cardiovascular magnetic resonance and serial fractional flow reserve assessment of the left anterior descending artery in patients undergoing right coronary artery chronic total occlusion revascularization
Richard E Jones, Grigoris V Karamasis, Jason N Dungu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
March 24, 2018
The impact of coronary chronic total occlusion percutaneous coronary intervention upon donor vessel fractional flow reserve and instantaneous wave-free ratio: Implications for physiology-guided PCI in patients with CTO
Shah R Mohdnazri, Grigoris V Karamasis, Firas Al-Janabi, et al.
European Journal of Heart Failure
|
February 15, 2020
Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study
Upasana Tayal, Ricardo Wage, Simon Newsome, et al.
European Heart Journal. Cardiovascular Imaging
|
November 10, 2025
A double-blind, randomised placebo-controlled trial examining the effect of MitoQ on myocardial energetics in patients with dilated cardiomyopathy
Brian P Halliday, Ruth Owen, Aaraby Ragavan, et al.
ESC Heart Failure
|
September 8, 2025
A novel treatment score (QUAD score) to promote treatment optimization in heart failure with a reduced ejection fraction
Henry Oluwasefunmi Savage, Jason N Dungu, Anthony Dimarco, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Heart (British Cardiac Society)
|
August 21, 2021
Dilated cardiomyopathy: the role of genetics, highlighted in a family with Filamin C (FLNC) variant
Jason N Dungu, Samantha G Langley, Amy Hardy-Wallace, et al.
Open Heart
|
April 17, 2025
Tale of three services: early UK experience with mavacamten treatment for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction
Edward Burford, Yande Kasolo, Jane Draper, et al.
Journal of Cardiac Failure
|
April 25, 2017
Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings
Hitesh C Patel, Carl Hayward, Jason N Dungu, et al.
Circulation. Heart Failure
|
September 14, 2016
Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis
Jason N Dungu, Sofia A Papadopoulou, Katharine Wykes, et al.
JACC. Cardiovascular Imaging
|
January 14, 2014
CMR-based differentiation of AL and ATTR cardiac amyloidosis
Jason N Dungu, Oswaldo Valencia, Jennifer H Pinney, et al.
Cardiology Journal
|
February 11, 2020
Stress perfusion cardiovascular magnetic resonance and serial fractional flow reserve assessment of the left anterior descending artery in patients undergoing right coronary artery chronic total occlusion revascularization
Richard E Jones, Grigoris V Karamasis, Jason N Dungu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
March 24, 2018
The impact of coronary chronic total occlusion percutaneous coronary intervention upon donor vessel fractional flow reserve and instantaneous wave-free ratio: Implications for physiology-guided PCI in patients with CTO
Shah R Mohdnazri, Grigoris V Karamasis, Firas Al-Janabi, et al.
European Journal of Heart Failure
|
February 15, 2020
Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study
Upasana Tayal, Ricardo Wage, Simon Newsome, et al.
European Heart Journal. Cardiovascular Imaging
|
November 10, 2025
A double-blind, randomised placebo-controlled trial examining the effect of MitoQ on myocardial energetics in patients with dilated cardiomyopathy
Brian P Halliday, Ruth Owen, Aaraby Ragavan, et al.
ESC Heart Failure
|
September 8, 2025
A novel treatment score (QUAD score) to promote treatment optimization in heart failure with a reduced ejection fraction
Henry Oluwasefunmi Savage, Jason N Dungu, Anthony Dimarco, et al.
Page
of 3